Cowen to host conference call to discuss first quarter 2021 financial results on Thursday, April 29. Click here for more information.

Gene Therapy: CMC & Regulatory Summit

Cowen’s Gene Therapy Summit is a virtual event focused on the gene therapy clinical development space, with a focus on the current state of the regulatory landscape. Panel topics will include:

  • FDA/CBER’s approach to gene therapy reviews given the ongoing COVID pandemic
  • Current and potentially changing requirements for pivotal clinical datasets
  • The current state of gene therapy CMC standards
  • The role and contribution of patient-focused drug development in gene therapy reviews and access.

Cowen is partnering with the EveryLife Foundation for Rare Diseases, a 501(c)(3) nonprofit, nonpartisan organization dedicated to empowering the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments and cures.


The Right Way to Access Care | Rightway Healthcare CEO, Jordan Feldman

Read More
Ahead of the Curve®

Investor’s Guide to Immuno-Oncology: Focus on Novel Targets

Read More

The Need for New Models of Primary Care | Scott Shreeve, Co-Founder & CEO, Crossover Health

Read More